In a six-month clinical trial in the United States, a drug test on 14 patients with rectum or “rectum” surprised everyone, and this group of fourteen had no signs of cancer at the end of the trial period.
The experiment was performed under the supervision of researchers at the Sloan Catering Memorial Cancer Center in New York, and a drug called dostarlimab completely wiped out cancerous tumors in infected participants.
According to the New England Journal of Medicine, a dose of the drug is injected into cancer participants every three weeks, and doctors predict that after the end of the trial period, standard cancer treatments such as chemotherapy and radiation will be started. By the end of the period, however, the results were amazing and the cancer cells had been removed from all the patients.
“This is the first time in the history of cancer treatment that this has happened,” said Dr. Luis Diaz Jr. of the Memorial Sloan Catering Cancer Center. “I have never seen a test in which all of the participating test specimens used were fully recovered after testing and treatment.”
The patients in the study had a type of colorectal cancer called mismatch repair-deficient, which often responds poorly to chemotherapy programs.
This test not only caused the tumors to disappear from the bodies of 14 patients, but also the side effects of using this new drug on them were zero.
Certain proteins, called “control points” in the body, act as a “brake” on the body’s immune cells, preventing them from responding strongly to cancer cells.
Now this experiment has shown that taking this drug will inhibit the control points or remove the “brake” and thus increase the multiplier strength of immune cells against cancer cells.
